ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway

Liu, Chunping; Chen, Guiling; Chen, Yanfen; Dang, Yue; Nie, Guangning; Wu, Dinghong; Li, Jinhua; Chen, Zide; Yang, Hailong; He, Dongyue; Li, Xiong; Sun, Jingbo; Lu, Jiahong*; Wang, Lei*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2021-9-8DOI: 10.3389/fphar.2021.724670
9被引3阅读
引用收藏
分享

摘要

Atherosclerosis (AS) is a type of chronic vascular disease, and its etiology is not yet fully understood. AS is characterized by lipid deposition, atherosclerotic plaque formation, vascular stenosis or even complete blockage of the blood vessel wall. Clinical studies have shown that Danlou tablets (DLTs) can improve the heart function, quality of life, and prognosis of patients with coronary heart disease and myocardial infarction. However, its mechanism of action remains unknown. Our study revealed that DLTs ameliorated ApoE(-/-)AS mouse aortic atherosclerotic plaques [hematoxylin-eosin (HE) staining and small animal ultrasound] and reduced CD68(+) macrophage infiltration, the expression of the inflammatory factor interferon-gamma (IFN-gamma), vascular smooth muscle alpha-actin, and serum lipid levels. In vitro, in the macrophage foaming model, DLTs partially restored the activity of RAW264.7 cells, reduced the uptake of lipid droplets, and inhibited lipid droplet accumulation and apoptosis within BMDMs. We also found that Torin1, an autophagy agonist, reduced intracellular lipid deposition in BMDMs, as did DLTs. Moreover, DLTs upregulated the expression of the autophagy-related protein LC3II and decreased p62 accumulation in RAW264.7 cells. DLTs also inhibited the phosphorylation of p-PI3K, p-Akt, and p-mTOR, leading to upregulated autophagy in RAW264.7 cells. In summary, our results suggested that DLTs can promote autophagy in macrophages by inhibiting the PI3K/Akt/mTOR signaling pathway, thereby reducing foam cell formation and improving atherosclerosis.

学科与关键词

关键词
atherosclerosisdanlou tabletsapolipoprotein E deficient micemacrophageautophagyPI3KAktmTOR signaling pathway
相关
加载中…
  • Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis
    Liao, Minqi; Hu, Feng; Qiu, Zhiqiang; Li, Juan; Huang, Chahua; Xu, Yan*; Cheng, XiaoshuAging-US, 2021, 13(18): 22412-22431.被引 5
  • Xinmaikang-mediated mitophagy attenuates atherosclerosis via the PINK1/Parkin signaling pathway
    Cao, Yanhong; Chen, Xin; Pan, Fuqiang; Wang, Mingyang; Zhuang, Haowen; Chen, Jiangna; Lu, Lu; Wang, Lingjun*; Wang, Ting*PHYTOMEDICINE, 2023, 119: 154955.被引 1
  • Aloe-emodin derivative produces anti-atherosclerosis effect by reinforcing AMBRA1-mediated endothelial autophagy
    Tang, Xueqing; Zhang, Yue; Liu, Xin; Li, Xiaohan; Zhao, Hongrui; Cui, Hao; Shi, Yang; Chen, Yongchao; Xu, Honglin; Meng, Ziyu; Zhao, Limin; Chen, Hui; Wang, Zhixia; Zhu, Mengying; Lin, Yuan; Yang, Baofeng*; Zhang, YongEuropean Journal of Pharmacology, 2022, 916: 174641.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-09-08
卷期
第 12 卷
页码
724670
DOI
10.3389/fphar.2021.724670
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82174161, 82104495, 81804132]; Science and Technology Foundation of Guangzhou City [202102010257]; Scientific research projects of Guangdong Bureau of traditional Chinese Medicine [20200513093851]; Guangdong Basic and Applied Basic Research Foundation [2021A1515012573, 2019A1515111108]; TCM Research Fund of Guangdong Provincial Hospital of Chinese Medicine [YN2019MJ15]; Research Fund of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ21]; Research Fund of Guangdong Provincial Key Laboratory of Research on Emergency in TCM [2019-40]

作者

  • L

    Liu, Chunping (第一作者)

    2 · guangzhou univ chinese med · guangdong prov hosp

  • C

    Chen, Guiling

    2 · guangzhou univ chinese med · guangdong prov hosp

查看全部 14 位作者收起作者
  • C

    Chen, Yanfen

  • D

    Dang, Yue

    shenyang pharmaceut univ

  • N

    Nie, Guangning

    2 · guangzhou univ chinese med

  • W

    Wu, Dinghong

    2 · guangzhou univ chinese med

  • L

    Li, Jinhua

    2 · guangzhou univ chinese med

  • C

    Chen, Zide

    guangdong prov peoples hosp

  • Y

    Yang, Hailong

    guangdong prov hosp

  • H

    He, Dongyue

    guangdong prov hosp

  • L

    Li, Xiong

    2 · guangzhou univ chinese med

  • S

    Sun, Jingbo

  • L

    Lu, Jiahong (通讯)

  • W

    Wang, Lei (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417